0001485003-16-000168.txt : 20160922 0001485003-16-000168.hdr.sgml : 20160922 20160922164529 ACCESSION NUMBER: 0001485003-16-000168 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160920 FILED AS OF DATE: 20160922 DATE AS OF CHANGE: 20160922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 252025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-9911 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Celniker Abbie CENTRAL INDEX KEY: 0001590250 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 161897999 MAIL ADDRESS: STREET 1: C/O ELEVEN BIOTHERAPEUTICS, INC. STREET 2: 215 FIRST STREET, SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wf-form4_147457710338447.xml FORM 4 X0306 4 2016-09-20 0 0001485003 Eleven Biotherapeutics, Inc. EBIO 0001590250 Celniker Abbie C/O ELEVEN BIOTHERAPEUTICS, INC., 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142 1 0 0 0 Stock Option (Right to Buy) 0.28 2016-09-20 4 A 0 29988 0 A 2016-09-20 2026-02-24 Common Stock 29988.0 90000 D On February 25, 2016, the reporting person was granted an option to purchase 90,000 shares of common stock. This option vests in installments based on the achievement of certain regulatory and business milestones. The Compensation Committee of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 29,988 shares. The option had previously vested with respect to 60,012 shares. /s/ John J. McCabe as attorney-in-fact 2016-09-22